Re-DiffiNet: Modeling discrepancies in tumor segmentation using diffusion models

Abstract: Identification of tumor margins is essential for surgical decision-making for glioblastoma patients and provides reliable assistance for neurosurgeons. Despite improvements in deep learning architectures for tumor segmentation over the years, creating a fully autonomous system suitable for clinical floors remains a formidable challenge because the model predictions have not yet reached the desired level of accuracy and generalizability for clinical applications. Generative modeling techniques have seen significant improvements in recent times. Specifically, Generative Adversarial Networks (GANs) and Denoising-diffusion-based models (DDPMs) have been used to generate higher-quality images with fewer artifacts and finer attributes. In this work, we introduce a framework called Re-Diffinet for modeling the discrepancy between the outputs of a segmentation model like U-Net and the ground truth, using DDPMs. By explicitly modeling the discrepancy, the results show an average improvement of 0.55\% in the Dice score and 16.28\% in HD95 from cross-validation over 5-folds, compared to the state-of-the-art U-Net segmentation model.

• The paper introduces Re-DiffiNet to model discrepancies between U-Net outputs and ground truth, achieving improved Dice scores by 0.55% and HD95 by 16.28%.
• Re-DiffiNet integrates U-Net predictions with 3D MRI scans using DDPM to generate corrective tumor mask predictions, refining segmentation results.
• The study demonstrates that modeling discrepancies significantly enhances tumor boundary identification, bolstering surgical decision-making in glioblastoma cases.

Enhancing Tumor Segmentation: Insights from Re-DiffiNet Using Diffusion Models

Introduction to the Challenge of Tumor Segmentation

Tumor segmentation, particularly for glioblastoma, plays a critical role in surgical decision-making, offering essential guidance for neurosurgeons. Despite advancements in deep learning architectures like U-Net and its variants, achieving the desired accuracy and generalizability for clinical applications remains a significant challenge. Recent developments in generative modeling, especially Denoising Diffusion Probabilistic Models (DDPMs), present new pathways to address these limitations by focusing on modeling discrepancies between the outputs of existing segmentation models and the ground truth.

Re-DiffiNet: A Novel Framework

Re-DiffiNet represents an innovative approach designed to tackle the inherent challenges of tumor segmentation more effectively. This framework introduces a strategy to model the discrepancy between a segmentation model's output (e.g., U-Net) and the ground truth segmentation. Through this lens, Re-DiffiNet leverages the capabilities of DDPMs to refine and optimize segmentation results while maintaining the foundational strengths of the U-Net architecture. This methodology has shown to improve average Dice scores by 0.55% and HD95 scores by 16.28% in cross-validation tests over 5-folds when compared to the state-of-the-art U-Net model, suggesting a notable enhancement in identifying tumor margins with higher precision.

Methodological Insight

Data and Preprocessing

The research utilized the BraTS2023 dataset comprising 3D MRI scans with segmentation annotations. This dataset, known for its comprehensive imaging volumes and rigorous segmentation labels, served as the foundation for training and evaluating the proposed models. Prior to model training, all MRI contrasts underwent Z-Score normalization, aligning with established preprocessing protocols for medical image analysis.

Architecture and Training

The core architecture of Re-DiffiNet builds on the U-Net augmented diffusion model, incorporating MRI scans and U-Net predictions as inputs to generate corrective tumor mask predictions. This advanced model architecture not only aims to replicate the original ground truth segmentation masks but also focuses on generating the discrepancy representations between the U-Net predictions and the actual ground truth. Various configurations were tested to optimize the input conditioning for the diffusion model, ultimately selecting the concatenation of MRI and U-Net prediction due to its superior performance. Training details encompassed the use of overlapping region metrics, compound loss functions, and implementation on NVIDIA A40 GPUs, highlighting a rigorously defined approach for model optimization.

Results and Discussion

The experiments conducted reveal that direct application of diffusion models to generate tumor masks yields modest improvements over baseline U-Net models. However, the significant advancement lies in the application of Re-DiffiNet to model discrepancies, resulting in marked improvements, especially in HD95 scores. These findings underscore the effectiveness of discrepancy modeling in refining tumor boundary predictions, a vital aspect for enhancing surgical planning accuracy.

Future Directions and Conclusion

While the current work showcases promising advancements in leveraging diffusion models for tumor segmentation, future explorations will aim to extend this methodology to various tumor types beyond gliomas. The potential for Re-DiffiNet to significantly improve segmentation accuracy illuminates a path forward for research in medical imaging and tumor diagnosis, promising to refine clinical decision-making processes further.

Acknowledgments and References

The study acknowledges the contributions of the research team and the support from the U.S. Department of Energy Computational Science Graduate Fellowship for one of its authors. References cited from foundational studies to recent advancements in DDPMs and tumor segmentation models provide a thorough backdrop for understanding the evolution and innovation within the field of medical image analysis.